Earnings · China A-shares
Shanghai Shen Lian Biomedical Corporation Class A (688098) earnings
Shanghai Shen Lian Biomedical Corporation Class A published its Q3 report on 2026-10-30: net profit -3910.20% year on year, -107.59% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +3.14% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -3910.20%
- Excl. one-offs YoY
- -107.59%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.43% | — |
| 3 days | +3.14% | — |
| 7 days | +3.43% | — |
| 14 days | -8.29% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +0.37%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥10.59M | -3910.20% | — | -19.54% | -0.03 | -0.76% | +3.14% | — | — |
| 2026 interim report | 2026-08-31 | -¥19.15M | -48.77% | -14.05% | -8.05% | -0.05 | -1.39% | +0.12% | -6.66% | +2.67% |
| 2026 Q1 report | 2026-04-29 | -¥1.73M | +42.68% | +58.88% | -20.50% | 0.00 | -0.12% | +3.55% | -4.47% | -5.41% |
| 2025 annual report | 2026-04-29 | -¥20.50M | +54.19% | +46.29% | -4.99% | -0.05 | -1.46% | +3.55% | -4.47% | -5.41% |
| 2025 Q3 report | 2025-10-27 | ¥278.05K | +101.97% | +67.18% | -4.27% | 0.00 | 0.02% | -3.72% | -14.14% | -13.91% |
| 2025 interim report | 2025-08-30 | -¥12.87M | +62.71% | +52.61% | -3.68% | -0.03 | -0.92% | -5.09% | -10.26% | -11.10% |
| 2025 Q1 report | 2025-04-30 | -¥3.02M | -36.70% | -55.10% | -10.58% | -0.01 | -0.21% | +4.20% | +8.59% | +5.41% |
| 2024 annual report | 2025-04-30 | -¥44.74M | -241.95% | — | +0.64% | -0.11 | -3.07% | +4.20% | +8.59% | +5.41% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.